HarborSite

HarborSite

Research-stage platform for inserting therapeutic genes into safe genomic sites with engineered recombinases

harborsite.com

Soha
Biotech
Joylashuv
United States

Tasdiqlangan daromad: hali ulanmagan

HarborSite sizningmi? Ushbu sahifani soʻrang va Stripe, App Store yoki Google Play’ni ulang: MRR va oʻsishingiz shu yerda toʻgʻridan-toʻgʻri manbadan koʻrinadi.

Sizniki boʻlsa, soʻrang

Startap haqida

HarborSite is a Harvard/Wyss Institute spinoff developing engineered recombinase enzymes to insert full-length therapeutic genes into safe sites in the genome, aiming at one-time treatments for genetic and age-related diseases. It is at research stage, with an initial focus on liver and blood cells. It is based in Boston, US, and is backed by Armenia-based SmartGate VC.

Jamoa

  • Erik Aznauryan, Co-founder and CEO (Asoschi)
  • George Church, Co-founder and Scientific Advisory Board Chair (Asoschi)
  • Tina Lebar, Co-founder and Scientific Advisory Board Member (Asoschi)

Auditoriya

Ijtimoiy tarmoqlardagi kuzatuvchilar

Profil maʼlumotlari manbasi: Stanbase.